Burning Rock Biotech Income Statement (2020-2025) | BNR

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 19.25M21.97M16.27M19.95M19.73M23.74M21.38M18.39M19.41M22.48M20.75M19.07M17.24M18.63M17.40M18.54M19.61M15.12M18.34M20.98M18.73M
Cost of Revenue 6.90M9.34M8.41M10.66M11.94M16.54M14.07M15.02M10.99M13.61M9.43M9.27M8.43M7.76M6.49M6.69M7.37M5.61M5.63M5.43M5.94M
Gross Profit 14.20M16.48M11.74M14.15M14.27M16.98M13.82M11.59M13.78M15.91M14.38M13.09M11.61M12.08M11.87M13.06M13.97M10.75M13.42M15.26M14.06M
Operating items
Research & Development -26.57M-13.86M-11.82M-16.91M-10.87M-18.13M-18.85M-12.74M-13.54M-16.03M-13.75M-12.48M-11.31M-11.34M-9.14M-8.88M-7.64M-6.16M-5.57M-7.02M-5.90M
Selling, General & Administrative -26.40M71.44M-17.75M-18.25M-18.12M131.05M-22.36M-21.24M-17.63M143.63M-18.64M-8.60M-16.11M105.02M-13.67M-12.68M-5.62M-3.88M-4.31M-4.44M-4.51M
Other Operating Expenses -16.48M-99.40M-8.41M-10.66M-11.94M-170.41M-14.07M-15.02M-10.99M-178.39M-9.43M-9.27M-8.43M-131.09M-6.49M-6.69M-7.37M-10.42M-5.63M-5.43M-5.94M
Operating Expenses -69.45M-41.83M-37.98M-45.82M-40.93M-57.49M-55.28M-49.00M-42.16M-50.80M-41.82M-30.35M-35.84M-37.41M-29.30M-28.25M-20.63M-20.46M-15.52M-16.90M-16.35M
Operating Income -19.12M-25.35M-26.23M-31.68M-26.66M-40.51M-41.47M-37.41M-28.38M-34.89M-27.44M-17.26M-24.24M-25.33M-17.43M-15.19M-6.66M-9.71M-2.09M-1.63M-2.29M
EBIT -19.12M-25.35M-26.23M-31.68M-26.66M-40.51M-41.47M-37.41M-28.38M-34.89M-27.44M-17.26M-24.24M-25.33M-17.43M-15.19M-6.66M-9.71M-2.09M-1.63M-2.29M
Non-operating items
Other Non Operating Income -0.26M-0.18M0.01M0.08M-0.10M-0.12M0.05M-0.07M0.19M0.06M0.09M-0.13M0.06M-0.07M0.06M-0.03M-0.02M-0.03M-0.09M0.05M-0.35M
Non Operating Income -0.03M-0.01M-0.02M0.02M0.00M0.59M
Net income details
EBT -36.92M-25.48M-26.16M-31.68M-26.51M-40.53M-41.23M-36.92M-27.98M-34.40M-26.91M-16.61M-23.66M-24.55M-16.81M-14.73M-6.19M-8.95M-1.83M-1.34M-2.34M
Tax Provisions -0.07M0.18M0.00M-0.28M-0.06M-0.06M-0.06M-0.15M-0.03M-0.03M-0.03M-0.72M-0.03M-0.03M-0.03M
Profit After Tax -36.92M-25.48M-26.16M-31.93M-26.57M-40.35M-41.23M-36.93M-27.98M-34.68M-26.98M-16.67M-23.72M-24.71M-16.84M-14.76M-6.22M-9.68M-1.86M-1.38M-2.38M
Investment Income -12.08M-15.03M2.15M-5.39M0.95M-3.90M-0.48M4.46M2.67M-0.65M-0.82M2.09M-0.28M-0.40M0.08M0.13M-0.57M0.84M-0.01M-0.03M-0.24M
Income from Continuing Operations -36.92M-25.48M-26.16M-31.68M-26.44M-40.71M-41.23M-36.92M-27.98M-34.12M-26.85M-16.55M-23.59M-24.40M-16.79M-14.71M-6.16M-8.23M-1.80M-1.31M-2.31M
Consolidated Net Income -36.92M-25.48M-26.16M-31.68M-26.44M-40.71M-41.23M-36.92M-27.98M-34.12M-26.85M-16.55M-23.59M-24.40M-16.79M-14.71M-6.16M-8.23M-1.80M-1.31M-2.31M
Income towards Parent Company -36.92M-25.48M-26.16M-31.68M-26.44M-40.71M-41.23M-36.92M-27.98M-34.12M-26.85M-16.55M-23.59M-24.40M-16.79M-14.71M-6.16M-8.23M-1.80M-1.31M-2.31M
Net Income towards Common Stockholders -48.99M-40.51M-26.16M-35.17M-25.63M-44.26M-41.72M-36.45M-27.98M-34.68M-27.80M-15.85M-23.72M-24.71M-16.84M-14.76M-6.58M-9.32M-1.87M-1.41M-2.62M
Additional items
EPS (Basic) -0.48-0.40-0.25-0.34-0.25-0.42-0.40-0.35-0.27-0.33-0.27-0.15-0.23-0.24-0.16-0.14-0.06-0.09-0.02-0.01-0.02
Shares Outstanding (Weighted Average) 101.99M101.99M101.99M104.55M104.55M104.55M104.23M104.23M105.11M105.44M103.91M103.91M102.39M102.48M102.33M102.54M102.54M102.60M103.23M107.61M107.62M107.68M
EBITDA -49.00M-40.51M-24.01M-37.32M-25.63M-44.26M-41.72M-32.47M-25.31M-35.33M-27.80M-14.58M-23.99M-25.11M-16.75M-14.63M-6.79M-8.84M-1.87M-1.41M-2.62M
Interest Expenses -0.00M-0.10M-0.08M-0.09M-0.06M-0.02M
Tax Rate 0.25%0.80%0.23%0.36%0.26%0.63%0.15%0.18%0.48%8.10%1.69%2.53%1.32%